Menstrual Cycle Hormone Relaxin and ACL Injuries in Female Athletes: A Systematic Review.

Female athletes are at increased risk for anterior cruciate ligament (ACL) injuries. The influence of hormonal variation on female ACL injury risk remains ill-defined. Recent data suggests that the collagen-degrading menstrual hormone relaxin may cyclically impact female ACL tissue quality. This review aims to identify any correlation between menstrual relaxin peaks and rates of female ACL injury. A systematic review was performed, utilizing the MEDLINE, EMBASE, and CINAHL databases. Included studies had to directly address relaxin/female ACL interactions. The primary outcome variable was relaxin proteolysis of the ACL, at cellular, tissue, joint, and whole-organism levels. The secondary outcome variable was any discussed method of moderating relaxin levels, and the clinical results if available. AllThe numerous relaxin receptors on female ACLs upregulate local collagenolysis and suppress local collagen production. Peak serum relaxin concentrations (SRC) occur during menstrual cycle days 21-24; a time phase associated with greater risk of ACL injury. Oral contraceptives (OCPs) reduce SRC, with a potential ACLprotective effect. A reasonable correlative and plausible causative relationship exists between peak relaxin levels and increased risk of ACL injury in females, and further investigation is warranted. Level of Evidence: III. Copyright © The Iowa Orthopaedic Journal 2024.

Citation

Emily A Parker, Kyle R Duchman, Alex M Meyer, Brian R Wolf, Robert W Westermann. Menstrual Cycle Hormone Relaxin and ACL Injuries in Female Athletes: A Systematic Review. The Iowa orthopaedic journal. 2024;44(1):113-123

Mesh Tags

Substances

PMID: 38919370

search → result